What are the indications for initiating a cough‑assist (mechanical insufflation‑exsufflation) device in a 68‑year‑old man with amyotrophic lateral sclerosis who has a peak cough flow of 180 L/min, maximal expiratory pressure of 42 cm H₂O, mild bulbar involvement, and difficulty clearing secretions?

Indications for Cough-Assist Device in ALS

This patient meets clear criteria for mechanical insufflation-exsufflation (MI-E/cough-assist) initiation based on both his peak cough flow of 180 L/min and maximal expiratory pressure of 42 cm H₂O, combined with clinical difficulty clearing secretions.

Primary Indication Criteria Met

Your patient satisfies multiple threshold criteria that mandate cough augmentation:

• Peak cough flow 180 L/min: Falls between the critical thresholds of 160 L/min (associated with ineffective airway clearance) and 270 L/min (the screening threshold for assisted cough technologies) 1

• MEP 42 cm H₂O: Significantly below the 60 cm H₂O threshold where effective coughing is maintained, and approaching the 45 cm H₂O level where adequate cough flow is essentially absent 1

• Clinical symptoms: Active difficulty clearing secretions represents functional impairment regardless of numerical values 1

Evidence-Based Rationale

The ATS consensus statement explicitly recommends: "Use assisted cough technologies in patients whose clinical history suggests difficulty in airway clearance, or whose peak cough flow is less than 270 L/minute and/or whose maximal expiratory pressures are less than 60 cm H₂O" 1. Your patient meets all three criteria.

The 2024 UK guidelines reinforce this, stating that PCF <270 L/min in adults should prompt referral to specialist respiratory teams and consideration of airway clearance support 2. More critically, mechanical insufflation-exsufflation was found particularly important in preventing hospitalization or tracheostomy in patients with peak cough flows around 160 L/min 1.

Special Consideration: Bulbar Involvement

The mild bulbar involvement requires careful attention but does not contraindicate MI-E:

• Bulbar dysfunction can complicate MI-E effectiveness by impairing glottic closure and coordination 3
• However, studies demonstrate that MI-E can still produce effective peak cough flows even in patients with severe bulbar symptoms 4
• Individual testing is essential: The 2011 study comparing assisted cough techniques in ALS found that while the in-exsufflator was generally most effective, it wasn't always the best tool for every patient, emphasizing the need to test multiple techniques 4

Implementation Approach

1. Initiate MI-E now given the combination of objective measurements and symptomatic secretion difficulty
2. Test effectiveness by measuring assisted PCF with the device—target >270 L/min with assistance
3. Monitor bulbar function closely, as progressive bulbar weakness may reduce MI-E efficacy over time 3
4. Consider adjunctive techniques: Manual assisted cough or breath-stacking may complement MI-E, particularly if bulbar dysfunction worsens 5, 4
5. Caregiver training is mandatory: Non-professional caregivers can safely and effectively use MI-E with proper training and on-call professional support 6

Common Pitfalls to Avoid

• Don't wait for PCF to drop below 160 L/min: This represents severe impairment; intervention at 180 L/min is appropriate and evidence-based 1
• Don't rely on daytime SpO₂: Oxygen saturation monitoring is useful during respiratory illnesses but doesn't rule out ventilatory compromise 2
• Don't assume MI-E won't work with bulbar involvement: Test it—many bulbar patients still benefit significantly 4
• Don't use MI-E as monotherapy: Combine with lung volume recruitment techniques (breath-stacking) for optimal results 5

Expected Outcomes

MI-E has demonstrated effectiveness in preventing hospitalization, reducing need for tracheostomy, and improving secretion clearance in neuromuscular disease patients 1. The device is well-tolerated with reported complications limited to transient nausea, abdominal distention, and rare cardiac rhythm changes 1. In ALS specifically, early application guided by oximetry feedback has prevented hospitalization in multiple cases 6.

The 2023 American College of Chest Physicians guideline supports MI-E for patients with NMD and reduced cough effectiveness that cannot be adequately improved with alternative techniques 5, which describes your patient's current clinical situation precisely.